Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$7.31 USD
+0.08 (1.11%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $7.31 0.00 (0.00%) 7:48 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Price, Consensus and EPS Surprise
SAGE 7.31 +0.08(1.11%)
Will SAGE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SAGE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SAGE
Biogen Stock Declines 20.9% Year to Date: Time to Sell?
Sage Therapeutics (SAGE) Down 17.1% Since Last Earnings Report: Can It Rebound?
SAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
Sage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise
Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Tops Revenue Estimates
Other News for SAGE
Sage Therapeutics files automatic mixed securities shelf
Sage Therapeutics files prospectus to offer $250M of common stock
Sage Therapeutics files for $250M of common stock
Sage Potash Shares to Resume Trading
Sage Potash Announces Equipment Purchase and Financing